Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies

被引:14
作者
Chen, Yongjian [1 ]
Ma, Kang [2 ]
Xu, Peilong [3 ]
Si, Hongzong [3 ]
Duan, Yunbo [4 ]
Zhai, Honglin [5 ]
机构
[1] Qingdao Univ, Sch Publ Hlth, Qingdao 266071, Peoples R China
[2] Ningxia Med Univ, Sch Basic Med, Yinchuan 750004, Peoples R China
[3] Qingdao Univ, New Fibrous Mat & Modern Text State Key Lab, Qingdao 266071, Peoples R China
[4] Quantum Inst, Queenland Montessori Coll, Surrey, BC V3Z 0T3, Canada
[5] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China
来源
MOLECULES | 2022年 / 27卷 / 21期
关键词
antipsychotics; autism; azinesulfonamides; cyclic amine derivatives; ANTIPSYCHOTICS; 3D-QSAR;
D O I
10.3390/molecules27217285
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of the present study aims to develop a satisfactory model for predicting pro-social and pro-cognitive effects on azinesulfonamides of cyclic amine derivatives as potential antipsychotics. The three dimensional-quantitative structure affinity relationship (3D-QSAR) study was performed on a series of azinesulfonamides of cyclic amine derivative using comparative molecular similarity indices analysis (CoMSIA). The best statistical model of CoMSIA q2, r2, SEE and F values are 0.664, 0.973, 0.087, and 82.344, respectively. Based on the model contour maps and the highest activity structure of the 43rd compound, serial new structures were designed and the 43k1 compound was selected as the best structure. The dock results showed a good binding of 43k1 with the protein (PDB ID: 6A93). The QSAR model analysis of the contour maps can help us to provide guidelines for finding novel potential antipsychotics.
引用
收藏
页数:12
相关论文
共 20 条
[1]  
Canale V., 2017, BIOORGAN MED CHEM, V349, P889
[2]  
Chen H.S., 2022, CANC CELL RES, V9, P827
[3]   Local and landscape effects on the butterfly community in fragmented Midwest USA prairie habitats [J].
Davis, Jessica D. ;
Debinski, Diane M. ;
Danielson, Brent J. .
LANDSCAPE ECOLOGY, 2007, 22 (09) :1341-1354
[4]  
Dearden J. C., 2017, INT J QUANTITATIVE S, V2, P36, DOI [10.4018/IJQSPR.2017070104, 10.4018/ijqspr.2017070104, DOI 10.4018/IJQSPR.2017070104]
[5]  
Deng M., 2014, MONOGR STUDY ASD, V2, P37
[6]   Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists [J].
Duan, Xinli ;
Zhang, Xin ;
Xu, Binglin ;
Wang, Fang ;
Lei, Ming .
CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 88 (01) :142-154
[7]   A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia [J].
Friedman, Joseph I. ;
Carpenter, David ;
Lu, Jing ;
Fan, Jin ;
Tang, Cheuk Y. ;
White, Leonard ;
Parrella, Michael ;
Bowler, Stephanie ;
Elbaz, Zeinab ;
Flanagan, Lauren ;
Harvey, Philip D. .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) :59-63
[8]  
Gadaleta D., 2016, INT J QUANT STRUCT R, V1, P45, DOI DOI 10.4018/IJQSPR.2016010102
[9]  
Hornák V, 1999, GEN PHYSIOL BIOPHYS, V18, P231
[10]   Quality of life, gastrointestinal symptoms, sleep problems, social support, and social functioning in adults with autism spectrum disorder [J].
Leader, Geraldine ;
Barrett, Amy ;
Ferrari, Chiara ;
Casburn, Mia ;
Maher, Leanne ;
Naughton, Katie ;
Arndt, Sophia ;
Mannion, Arlene .
RESEARCH IN DEVELOPMENTAL DISABILITIES, 2021, 112